Q&A: EQT’s Andreas Aschenbrenner and Sophie Walker
In the past month, EQT has launched an impact fund with a difference and adopted science-based targets for emissions reduction. Andreas Aschenbrenner, deputy head of EQT Future, and Sophie Walker, head of sustainability for private capital, explain why
Q: How did the notion of EQT Future – a longer-dated, impact-focused fund – emerge? Andreas Aschenbrenner: We started thinking about it around the time of EQT’s IPO. We want to have a positive...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.